244
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Depression and HIV transmission risk among methamphetamine-using men who have sex with men

, &
Pages 263-270 | Received 27 Feb 2020, Accepted 07 Jul 2020, Published online: 25 Aug 2020

References

  • Babowitch JD, Mitzel LD, Vanable PA, Sweeney SM. 2018. Depressive symptoms and condomless sex among men who have sex with men living with HIV: a curvilinear association. Arch Sex Behav. 47(7):2035–2036.
  • Baeten JM. 2018. Amplifying the population health benefits of PrEP for HIV prevention. J Infect Dis. 217(10):1509–1511.
  • Bourne A, Weatherburn P. 2017. Substance use among men who have sex with men: patterns, motivations, impacts and intervention development need. Sex Transm Infect. 93(5):342–346.
  • Bousman CA, Cherner M, Ake C, Letendre S, Atkinson JH, Patterson TL, Grant I, Everall IP, HNRC Group 2009. Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV. J Affect Disord. 119(1–3):84–91.
  • Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, de Graaf R, Demyttenaere K, Hu C, Iwata N. 2011. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 9(1):90.
  • Buchacz K, McFarland W, Kellogg TA, Loeb L, Holmberg SD, Dilley J, Klausner JD. 2005. Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS. 19(13):1423–1424.
  • Burns DN, Grossman C, Turpin J, Elharrar V, Veronese F. 2014. Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies. Curr HIV/AIDS Rep. 11(4):393–403.
  • Carrico AW, Gómez W, Siever MD, Discepola MV, Dilworth SE, Moskowitz JT. 2015. Pilot randomized controlled trial of an integrative intervention with methamphetamine-using men who have sex with men. Arch Sex Behav. 44(7):1861–1867.
  • Centers for Disease Control and Prevention (CDC). 2018. HIV and gay and bisexual men. https://www.cdc.gov/hiv/pdf/group/msm/cdc-hiv-msm.pdf.
  • Colfax G, Shoptaw S. 2005. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep. 2(4):194–199.
  • Eshleman SH, Hudelson SE, Redd AD, Swanstrom R, Ou S-S, Zhang XC, Ping L-H, Piwowar-Manning E, Porcella SF, Sievers MF. 2017. Treatment as prevention: characterization of partner infections in the HIV prevention trials network 052 trial. J Acquir Immune Defic Syndr. 74(1):112–116.
  • First MB, Williams JB, Karg RS, Spitzer RL. 2016. SCID-5-CV: structured clinical interview for DSM-5 disorders. Washington, D.C.: American Psychiatric Association.
  • Fletcher JB, Reback CJ. 2015. Depression mediates and moderates effects of methamphetamine use on sexual risk taking among treatment-seeking gay and bisexual men. Health Psychol. 34(8):865–869.
  • Fletcher JB, Swendeman D, Reback CJ. 2018a. Associations between major depressive episode, methamphetamine use disorder severity, and engagement in sexual risk-taking among methamphetamine-using men who have sex with men. AIDS Behav. 22(5):1461–1466.
  • Fletcher JB, Swendeman D, Reback CJ. 2018b. Mental health and substance use disorder comorbidity among methamphetamine-using men who have sex with men. J Psychoact Drugs. 50(3):206–213.
  • Forrest DW, Metsch LR, LaLota M, Cardenas G, Beck DW, Jeanty Y. 2010. Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. J Urban Health. 87(3):480–485.
  • Garofalo R, Mustanski BS, McKirnan DJ, Herrick A, Donenberg GR. 2007. Methamphetamine and young men who have sex with men: understanding patterns and correlates of use and the association with HIV-related sexual risk. Arch Pediatr Adolesc Med. 161(6):591–596.
  • Halkitis PN, Parsons JT, Stirratt MJ. 2001. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission. J Homosex. 41(2):17–35.
  • Horvath KJ, Lammert S, MacLehose RF, Danh T, Baker JV, Carrico AW. 2019. A pilot study of a mobile app to support HIV antiretroviral therapy adherence among men who have sex with men who use stimulants. AIDS Behav. 23(11):3184–3198.
  • Javanbakht M, Shoptaw S, Ragsdale A, Brookmeyer R, Bolan R, Gorbach PM. 2020. Depressive symptoms and substance use: changes overtime among a cohort of HIV-positive and HIV-negative MSM. Drug Alcohol Depend. 207:107770.
  • King KA, Vidourek RA, Yockey RA. 2019. Social determinants to lifetime methamphetamine use among a national sample of adults. J Subst Use. 24(4):388–393.
  • Marquez C, Mitchell SJ, Hare CB, John M, Klausner JD. 2009. Methamphetamine use, sexual activity, patient–provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004–2006. AIDS Care. 21(5):575–582.
  • Mausbach BT, Semple SJ, Strathdee SA, Zians J, Patterson TL. 2007. Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the EDGE study. Drug Alcohol Depend. 87(2–3):249–257.
  • McKetin R, Lubman D, Lee N, Ross J, Slade T. 2011. Major depression among methamphetamine users entering drug treatment programs. Med J Australia. 195(S3):S51–S55.
  • O’Cleirigh C, Newcomb ME, Mayer KH, Skeer M, Traeger L, Safren SA. 2013. Moderate levels of depression predict sexual transmission risk in HIV-infected MSM: a longitudinal analysis of data from six sites involved in a “prevention for positives” study. AIDS Behav. 17(5):1764–1769.
  • Peck JA, Reback CJ, Yang X, Rotheram-Fuller E, Shoptaw S. 2005. Sustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men. J Urban Health. 82(1_suppl_1):i100–i108.
  • Plankey MW, Ostrow DG, Stall R, Cox C, Li X, Peck JA, Jacobson LP. 2007. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 45(1):85.
  • Rajasingham R, Mimiaga MJ, White JM, Pinkston MM, Baden RP, Mitty JA. 2012. A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine. AIDS Patient Care STDS. 26(1):36–52.
  • Reback CJ, Fletcher JB. 2018. Elevated HIV and STI prevalence and incidence among methamphetamine-using men who have sex with men in Los Angeles county. AIDS Educ Prev. 30(4):350–356.
  • Reback CJ, Fletcher JB, Shoptaw S, Mansergh G. 2015. Exposure to theory-driven text messages is associated with HIV risk reduction among methamphetamine-using men who have sex with men. AIDS Behav. 19(S2):130–141.
  • Reback CJ, Fletcher JB, Swendeman DA, Metzner M. 2019. Theory-based text-messaging to reduce methamphetamine use and HIV sexual risk behaviors among men who have sex with men: automated unidirectional delivery outperforms bidirectional peer interactive delivery. AIDS Behav. 23(1):37–47.
  • Reback CJ, Grant DL, Fletcher JB, Branson CM, Shoptaw S, Bowers JR, Charania M, Mansergh G. 2012. Text messaging reduces HIV risk behaviors among methamphetamine-using men who have sex with men. AIDS Behav. 16(7):1993–2002.
  • Reback CJ, Larkins S, Shoptaw S. 2004. Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS Behav. 8(1):87–98.
  • Reback C, Larkins S, Shoptaw S. 2003. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care. 15(6):775–785.
  • Reisner SL, Mimiaga MJ, Skeer M, Bright D, Cranston K, Isenberg D, Bland S, Barker TA, Mayer KH. 2009. Clinically significant depressive symptoms as a risk factor for HIV infection among black MSM in Massachusetts. AIDS Behav. 13(4):798–810.
  • Rogers G, Curry M, Oddy J, Pratt N, Beilby J, Wilkinson D. 2003. Depressive disorders and unprotected casual anal sex among Australian homosexually active men in primary care. HIV Med. 4(3):271–275.
  • Saag MS, Benson CA, Gandhi RT, Hoy JF, Landovitz RJ, Mugavero MJ, Sax PE, Smith DM, Thompson MA, Buchbinder SP. 2018. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2018 recommendations of the International Antiviral Society-USA Panel. JAMA. 320(4):379–396.
  • Shiu CS, Chen YC, Tseng PC, Chung AC, Wu MT, Hsu ST, Ko NY. 2014. Curvilinear relationship between depression and unprotected sexual behaviors among men who have sex with men. J Sex Med. 11(10):2466–2473.
  • Shoptaw S, Reback CJ. 2006. Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy. J Urban Health. 83(6):1151–1157.
  • Shoptaw S, Reback CJ. 2007. Methamphetamine use and infectious disease‐related behaviors in men who have sex with men: implications for interventions. Addiction. 102:130–135.
  • Solomon TM, Kiang MV, Halkitis PN, Moeller RW, Pappas MK. 2010. Personality traits and mental health states of methamphetamine-dependent and methamphetamine non-using MSM. Addict Behav. 35(2):161–163.
  • Weatherburn P, Hickson F, Reid D, Torres-Rueda S, Bourne A. 2017. Motivations and values associated with combining sex and illicit drugs (‘chemsex’) among gay men in South London: findings from a qualitative study. Sex Transm Infect. 93(3):203–206.
  • Wohl AR, Frye DM, Johnson DF. 2008. Demographic characteristics and sexual behaviors associated with methamphetamine use among MSM and non-MSM diagnosed with AIDS in Los Angeles County. AIDS Behav. 12(5):705–712.
  • Ybarra ML, Liu W, Prescott TL, Phillips G, Mustanski B. 2018. The effect of a text messaging based HIV prevention program on sexual minority male youths: a national evaluation of information, motivation and behavioral skills in a randomized controlled trial of guy2guy. AIDS Behav. 22(10):3310–3335.
  • Young LE, Schumm P, Alon L, Bouris A, Ferreira M, Hill B, Khanna AS, Valente TW, Schneider JA. 2018. PrEP Chicago: a randomized controlled peer change agent intervention to promote the adoption of pre-exposure prophylaxis for HIV prevention among young Black men who have sex with men. Clin Trials. 15(1):44–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.